Putensen, C.
Ellger, B.
Sakka, S. G.
Weyland, A.
Schmidt, K.
Zoller, M.
Weiler, N.
Kindgen-Milles, D.
Jaschinski, U.
Weile, J.
Lindau, S.
Kieninger, M.
Faltlhauser, A.
Jung, N.
Teschendorf, P.
Adamzik, M.
Gründling, M.
Wahlers, T.
Gerlach, H.
Litty, F.-A. http://orcid.org/0000-0001-5147-1011
Funding for this research was provided by:
InfectoPharm und Consilium GmbH
Article History
Received: 3 December 2018
Accepted: 16 May 2019
First Online: 12 June 2019
Compliance with ethical standards
:
: This study was funded by InfectoPharm Arzneimittel und Consilium GmbH (D) and Sandoz GmbH (AT). All participating study centers received contractually agreed study fees by InfectoPharm Arzneimittel und Consilium GmbH during the conduct of the present study. DKM reports grants from InfectoPharm during the conduct of the study and personal fees outside the submitted work. In the last three years, NJ has received lecture fees from Labor Stein, Novartis, Gilead, InfectoPharm and MSD and travel grants from Gilead, Novartis and Basilea. FAL is an employee of InfectoPharm Arzneimittel und Consilium GmbH. The other authors have nothing to disclose.
: The present study has been approved by the appropriate ethics committee and has, therefore, been conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.